Transcutaneous paCO2 Monitoring

From Guide to YKHC Medical Practices

Transcutaneous CO2 (TC-CO2) monitors function by measuring the CO2 which diffuses out the skin. Modern TC-CO2 monitors are a highly accurate, non-invasive method for estimating paCO2.[1]

Sentec.PNG



Primary Purpose

YKDRH obtained TC-CO2 monitors for the purpose of monitoring paCO2 trends in patients receiving high-flow nasal cannula or non-invasive ventilation (i.e. CPAP/BiPAP). This was necessary because end-tidal CO2 monitoring is not compatible with these interventions.


Important Points

  1. Applicable for all age groups (including extremely premature neonates).
  2. Initial reading requires approximately five minutes to establish.
  3. TC-CO2 is substantially more accurate than peripheral venous CO2 for estimating paCO2.[1]
  4. Because CO2 takes several minutes to diffuse out of the skin, the displayed TC-CO2 reading at any given time reflects the paCO2 from 2-4 minutes prior.
  5. The tracing is a flat line (rather than the waveform created by exhaled air).
  6. TC-CO2 is used to follow paCO2 trends; it DOES NOT measure instantaneous levels. Therefore, TC-CO2 IS NOT an acceptable substitute for ET-CO2 in situations such as:
    1. Confirmation of ET-tube placement.
    2. CPR (neither for CPR adequacy nor ROSC identification).
    3. Respiratory monitoring during sedation.
    4. Any situation where monitoring for apnea or any rapid changes in paCO2.
  7. The accuracy of end-tidal CO2 as an estimate of paCO2 is largely dependent upon how closely a patient's lung function matches an ideal lung. For patients who are intubated for non-respiratory issues, their lung function should pretty closely approximate an ideal lung, and thus end-tidal CO2 should estimate paCO2 with reasonable accuracy. But for patients with lung processes which create V/Q mismatches, end-tidal CO2 is not a good estimate of paCO2. In such situations, TC-CO2 provides a MUCH MORE ACCURATE estimate paCO2.[1] Thus, if paCO2 requires monitoring in patients with ARDS, bronchiolitis, pneumonia, etc., TC-CO2 should be considered regardless of the type of respiratory support the patient is receiving (i.e. none, high-flow, or intubated). In such a situation, an intubated patient might be monitored with end-tidal CO2 to watch for apnea and TC-CO2 to assess adequacy of ventilation over time.


Device

YKDRH has acquired the Sentec Digital Monitoring System.
The Sentec devices provides monitoring of:

  1. Instantaneous oximetry (with an adjustable duration trend line)
  2. Instantaneous heart rate (with an adjustable duration trend line)
  3. Delayed paCO2 (with an adjustable duration trend line)

Resources

Sentec Instruction Manual

Instructional Videos:

Sensor Application Neonatal for the Sentec Digital Transcutaneous Monitoring System
Sensor Application Adult Cheek for the Sentec Digital Transcutaneous Monitoring System
Sensor Application Adult Upper Arm for the Sentec Digital Transcutaneous Monitoring System
Changing the Sensor Membrane for the Sentec Digital Transcutaneous Monitoring System
Sentec Digital Transcutaneous Monitoring System Demonstration


PubMed Searches:

("transcutaneous co2"[Title] OR "transcutaneous carbon dioxide"[Title]) AND (infant[Title] OR neonat*[Title] OR child*[Title])


REFERENCES

  1. 1.0 1.1 1.2 Nassar BS, Schmidt GA. Estimating Arterial Partial Pressure of Carbon Dioxide in Ventilated Patients: How Valid Are Surrogate Measures? Ann Am Thorac Soc. 2017 Jun;14(6):1005-1014. doi: 10.1513/AnnalsATS.201701-034FR. PMID: 28570147.